Singapore, Sept. 21 -- Swiss pharma firm Roche has announced the grand opening of the Roche Genentech Innovation Center Boston, expanding Roche and Genentech's US research presence in one of the world's leading life sciences communities.

Located at Harvard's Enterprise Research Campus in Allston, the Roche Genentech Innovation Center Boston will serve as Roche's Cardiovascular, Renal and Metabolism (CVRM) hub, establishing a significant end-to-end R&D presence in CVRM.

With the new centre, Roche and Genentech are expanding their footprint within the Greater Boston innovation ecosystem, leveraging local talent and anchoring an entrepreneurial hub at Harvard's Enterprise Research Campus. It brings together scientists from across discovery...